Pediatric antibiotic commercial formulation innovation opportunity — the WHO's Essential Medicines for Children program's identification of pediatric antibiotic access as a global health priority, the documented commercial gap between the antibiotic formulations available for adult patients — primarily tablet and capsule oral dosage forms — and the child-appropriate liquid...